In line with our findings, a prospective clinical study including patients with solid tumors (breast and NSCLC) has demonstrated exosomal Hsp70 levels to inversely correlate with therapeutic response [66]. The gene discussed is HSPA1A; the disease is non-small cell lung carcinoma.